focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 375.00
Bid: 370.00
Ask: 380.00
Change: 5.00 (1.35%)
Spread: 10.00 (2.703%)
Open: 370.00
High: 375.00
Low: 370.00
Prev. Close: 375.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit

Tue, 05th Mar 2024 20:43

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Beeks Financial Cloud Group PLC - Glasgow-based cloud computing and connectivity provider - Swings to pretax profit of GBP158,000 in the six months to December 31, from a loss of GBP762,000 a year prior. Revenue climbs 25% to GBP13.0 million from GBP10.4 million. Cost of sales increase 31% to GBP8.2 million from GBP6.2 million, while admin expenses decrease 4.2% to GBP4.7 million from GBP4.9 million. Looking ahead, Chief Executive Officer Gordon McArthur says the company is confident as it was underlining "the size of the opportunity we are addressing. Financial markets are still only at the start of the journey to the cloud. With our proven offering and growing tier 1 customer base, which includes some of the largest financial organisations in the world, as well as our increasing profit margins and cash generation, we have never been better placed to seize the opportunity. Our focus for the second half remains the conversion of our significant pipeline."

----------

dotdigital Group PLC - London-based online marketing company - Pretax profit edges down negligibly to GBP7.38 million in the six months to December 31, from GBP7.42 million a year prior. Revenue however grows 15% to GBP38.7 million from GBP33.8 million. Cost of sales increase 14% to GBP8.0 million from GBP7.1 million. Administrative expenses increase 16% to GBP22.4 million from GBP19.2 million. Looking ahead, the company says it enters the second financial half "with good trading momentum and the ability to attract higher value deals, underpinned by continuous product enhancements to drive cross- and up-sells from the existing base." It adds: "We remain confident in the group's ability to continue to execute against its stated strategy and meet market expectations."

----------

MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Confirms 2023 results it had announced in January. Further, expects core revenue growth of between none and 5% in 2024 compared to 2023. Expects strategic platform license programme-related revenue of around USD3 million for the year, down sharply from USD11.4 million in 2023. CEO Maher Masoud says: "As we continue to expand our SPL portfolio this year, we remain confident in our ability to support our current and prospective clients as new waves of next-generation cell therapies come to market."

----------

Origin Enterprises PLC - Dublin-based agronomy services firm - Pretax profit dives 96% to EUR5.3 million in the six months to January 31, from EUR13.3 million a year prior. Revenue drops 28% to EUR854.9 million from EUR1.18 billion. Notes an expected correction in global feed and fertiliser raw materials regarding decline in revenue. Despite the results, maintains interim dividend at 3.15 euro cents per share. Looking ahead, says on-farm sentiment remains cautious as growers shift towards spring planting and seek to optimise yields from a reduced autumn/winter planted area. Further, expects financial 2024 earnings per share between 44 and 49 euro cents, reflecting adverse weather. This compares to EPS of 45.24c Origin Enterprises had reported for financial 2023.

----------

Thor Energy PLC - US and Australia-focused mineral exploration company - Pretax loss widens to GBP2.3 million in the six months to December 31, from GBP8,000 a year prior. Posts no revenue. Notes costs regarding a write off of exploration assets of around GBP1.9 million in the most recent half-year, compared to no such cost a year prior. Managing Director Nicole Warland says: "After ending the year with consistent high-grade uranium results from our 2023 drilling program, we are optimistic about our 2024 drilling programs as we continue to strategically position our portfolio towards advancing our 'green energy' projects in the US." She adds: "With a strong pipeline of news flow expected for the coming months and project milestones across the portfolio, we anticipate 2024 to provide significant progress in our key assets and we will provide further updates in due course."

----------

Time Out Group PLC - Global media and hospitality business - Pretax loss narrows 63% to GBP4.6 million in the six months to December 31, from GBP12.5 million a year prior. Revenue falls 2.4% to GBP52.5 million from GBP53.8 million. However, like-for-like revenue in constant currency climbs 6.9% to GBP54.9 million from GBP51.4 million. Time Out says it has made "significant" further progress in driving profitability and operational cash generation. It says it has several potential growth avenues, citing collaboration with leading landlords and developers.

----------

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 Jan 2024 14:04

MaxCyte teams with Singapore-based Lion to support TCR-T cell work

(Alliance News) - MaxCyte Inc on Wednesday said it had signed a strategic platform licence with Lion TCR to promote the latter's T cell receptor-T cell pipeline.

Read more
2 Jan 2024 11:25

Maher Masoud starts as MaxCyte president, CEO

(Sharecast News) - MaxCyte confirmed the appointment of Maher Masoud as its new president and chief executive officer on Tuesday, effective from 1 January.

Read more
12 Dec 2023 15:56

TRADING UPDATES: Technology Minerals identifies lithium at Knockeen

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
12 Dec 2023 13:46

MaxCyte announces new CEO, updates revenue guidance

(Sharecast News) - Cell engineering technology specialist MaxCyte announced a significant chief executive transition on Tuesday and updated its revenue guidance for 2023.

Read more
16 Nov 2023 13:57

MaxCyte joins Alliance for mRNA Medicines

(Sharecast News) - Cell engineering company MaxCyte announced its membership in the Alliance for mRNA Medicines (AMM) as a founding member on Thursday.

Read more
9 Nov 2023 14:14

EARNINGS AND TRADING: Chapel Down hopes to make splash on AIM

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
1 Nov 2023 15:44

UK earnings, trading statements calendar - next 7 days

Thursday 2 November 
BT Group PLCHalf Year Results
Derwent London PLCTrading Statement
Entain PLCTrading Statement
Haleon PLCQ3 Results
Helios Towers PLCQ3 Results
Hikma Pharmaceuticals PLCTrading Statement
Howden Joinery Group PLCTrading Statement
J Sainsbury PLCHalf Year Results
Kin & Carta PLCFull Year Results
OSB Group PLCTrading Statement
Shell PLCQ3 Results
Smith & Nephew PLCQ3 Results
TI Fluid Systems PLCTrading Statement
Trainline PLCHalf Year Results
Friday 3 November 
no events scheduled 
Monday 6 November 
Kingspan Group PLCTrading Statement
Kosmos Energy LtdQ3 Results
Ryanair Holdings PLCHalf Year Results
Tuesday 7 November 
Associated British Foods PLCFull Year Results
Beazley PLCQ3 Results
Direct Line Insurance Group PLCTrading Statement
dotdigital Group PLCFull Year Results
IWG PLCQ3 Results
Persimmon PLCTrading Statement
RS Group PLCHalf Year Results
Vaalco Energy IncQ3 Results
Watches of Switzerland Group PLCTrading Statement
Wednesday 8 November 
Conduit Holdings LtdQ3 Results
ITV PLCTrading Statement
JD Wetherspoon PLCQ1 Results
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Secure Trust Bank PLCTrading Statement
Smiths News PLCFull Year Results
Time Out Group PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
5 Oct 2023 13:00

MaxCyte lowers full-year guidance after weaker third quarter

(Sharecast News) - Cell engineering specialist MaxCyte revised its full-year guidance downwards on Thursday based on its preliminary third-quarter revenue.

Read more
5 Oct 2023 10:16

AIM WINNERS & LOSERS: SDX Energy receives gas prepayment from Citic

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
5 Oct 2023 10:08

MaxCyte shares fall as warns of sharp revenue drop, citing volatility

(Alliance News) - MaxCyte Inc on Thursday said it expects revenue in the third quarter and for all of 2023 to fall from a year before, citing volatility in customer activity in the life science tools sector.

Read more
10 Aug 2023 10:22

MaxCyte shares fall as revenue plummets in first half, loss widens

(Alliance News) - MaxCyte Inc on Thursday reported an increased loss in the first half of 2023, as revenue fell while costs increased.

Read more
2 Aug 2023 15:46

UK earnings, trading statements calendar - next 7 days

Thursday 3 August 
Helios Towers PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Irish Residential Properties REIT PLCHalf Year Results
London Stock Exchange Group PLCHalf Year Results
Mears Group PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Omega Diagnostics Group PLCFull Year Results
Pantheon International PLCFull Year Results
Pets At Home Group PLCTrading Statement
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Serco Group PLCHalf Year Results
Shaftesbury Capital PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Walker Crips Group PLCFull Year Results
Wizz Air Holdings PLCQ1 Results
Friday 4 August 
Capita PLCHalf Year Results
Renewables Infrastructure Group LtdHalf Year Results
WPP PLCHalf Year Results
Monday 7 August 
HydrogenOne Capital Growth PLCTrading Statement
Kosmos Energy LtdHalf Year Results
PageGroup PLCHalf Year Results
Tuesday 8 August 
abrdn PLCHalf Year Results
Glencore PLCHalf Year Results
H&T Group PLCHalf Year Results
InterContinental Hotels Group PLCHalf Year Results
IWG PLCHalf Year Results
Quilter PLCHalf Year Results
Rotork PLCHalf Year Results
SDI Group PLCFull Year Results
SIG PLCHalf Year Results
TI Fluid Systems PLCHalf Year Results
Zotefoams PLCHalf Year Results
Wednesday 9 August 
4imprint Group PLCHalf Year Results
Arix Bioscience PLCHalf Year Results
Bank of Cyprus Holdings PLCHalf Year Results
Bellway PLCTrading Statement
CLS Holdings PLCHalf Year Results
CML Microsystems PLCTrading Statement
Coca-Cola HBC AGHalf Year Results
Flutter Entertainment PLCHalf Year Results
Hargreaves Services PLCFull Year Results
Hill & Smith PLCHalf Year Results
Hiscox LtdHalf Year Results
MaxCyte IncHalf Year Results
Polymetal International PLCTrading Statement
RM PLCHalf Year Results
Secure Trust Bank PLCHalf Year Results
TP ICAP Group PLCHalf Year Results
Tui AGQ3 Results
Vaalco Energy IncHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Aug 2023 14:26

TRADING UPDATES: MaxCyte strikes deal; Barkby sells Workshop

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
10 Jul 2023 14:05

MaxCyte inks deal with Vittoria Therapeutics for cellular therapies

(Alliance News) - MaxCyte Inc on Monday said it signed a strategic platform licence with Vittoria Biotherapeutics to advance cellular therapies.

Read more
10 Jul 2023 13:20

MaxCyte signs licence deal with Vittoria Biotherapeutics

(Sharecast News) - MaxCyte announced a strategic platform licence agreement with Vittoria Biotherapeutics on Monday, granting Vittoria non-exclusive clinical and commercial rights to use MaxCyte's 'Flow Electroporation' technology and 'ExPERT' platform.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.